© 2024 NUVO Magazine Ltd.
Casgevy is the world’s first government-approved, effective gene-edited cell therapy to treat sickle-cell disease.
Long stigmatized, these substances are coming into the mainstream. We talk with the experts about the future of their recreational, therapeutic, and business potentials.
Researchers at the University of Glasgow have developed a new weapon in humanity’s ongoing war against cancer.
As the world’s aging population grows, a new host of tools designed for the dying has emerged.
Thirteen years, three billion dollars. That’s the size of the investment made to map the human genome in its entirety, give or take a few months and a few million. While scientists completed the effort over a decade ago, we’re only starting to reap the returns.
